| Trial ID: | L2078 |
| Source ID: | NCT00348231
|
| Associated Drug: |
Dual-Action Insulin Analog
|
| Title: |
Jikei Optimal Insulin Therapy in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: dual-action insulin analog
|
| Outcome Measures: |
Primary: HbA1c|daily profile of blood glucose | Secondary: IMT|QOL
|
| Sponsor/Collaborators: |
Sponsor: Jikei University School of Medicine | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-11
|
| Completion Date: |
2006-08
|
| Results First Posted: |
|
| Last Update Posted: |
2006-09-01
|
| Locations: |
The Jikei university school of medicine division of diabetes and endoclinology dept. of internal medicine, Tokyo, 1058461, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00348231
|
